Next Article in Journal
Hybrid Mortars Activated with Alternative Steel-Compatible Salts: Impact on Chloride Diffusion and Durability
Next Article in Special Issue
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors
Previous Article in Journal
Geochemical Characteristics and Thermal Evolution History of Jurassic Tamulangou Formation Source Rocks in the Hongqi Depression, Hailar Basin
Previous Article in Special Issue
Labeling Peptides with Radioiodine: An Overview of Traditional and Emerging Techniques
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Synthetic Approaches to 1,3,4-Oxadiazole-Containing Boronic Derivatives

by
Barbara Wołek
1 and
Agnieszka Kudelko
2,*
1
Selvita S.A., Podole 79, PL-30394 Kraków, Poland
2
Department of Chemical Organic Technology and Petrochemistry, The Silesian University of Technology, Krzywoustego 4, PL-44100 Gliwice, Poland
*
Author to whom correspondence should be addressed.
Appl. Sci. 2025, 15(14), 8054; https://doi.org/10.3390/app15148054
Submission received: 16 June 2025 / Revised: 16 July 2025 / Accepted: 17 July 2025 / Published: 19 July 2025
(This article belongs to the Special Issue Research on Organic and Medicinal Chemistry)

Abstract

1,3,4-Oxadiazoles containing boronic acid moieties are promising as a highly versatile class of compounds with significant utility across various scientific domains. The diverse synthetic methodologies for their preparation make these compounds valuable precursors for developing novel entities with tailored properties in medicinal chemistry, agrochemistry, and materials science. This review systematically compiles and discusses synthetic methods for the direct and indirect incorporation of boronic acid derivatives into 1,3,4-oxadiazole scaffolds. Understanding these strategies is particularly important because of their key role in modern synthetic transformations, especially Suzuki–Miyaura cross-coupling reactions, which enable easy access to a new generation of structurally diverse 1,3,4-oxadiazole-based compounds. The synthetic procedures and reactions discussed are based on the currently available literature, offering a comprehensive overview of this rapidly evolving field.

1. Introduction

Boron, the fifth element in the periodic table, is a small atom and a semimetal from the p-block, containing three valence electrons. This leads to remarkable potential in its chemistry, especially in the field of organoboron compounds [1]. Elemental boron is used as a dopant in semiconductors, while its derivatives are widely exploited in the production of glass, ceramics and glass fibers, wood preservatives and insecticides, as well as detergents and bleaching agents [1,2]. It also plays a fundamental role in organic synthesis. Boronic acids (Figure 1) are organic derivatives of boric acid, B(OH)3, in which one hydroxyl group is replaced by an alkyl or aryl group (represented as R in the general formula R–B(OH)2). Boronic esters, such as the well-known pinacol boronic ester, are formed by the reaction of boronic acids with alcohols. In addition to traditional boronic acids and esters, new classes of organoboron compounds—including trifluoroborate salts and MIDA (methyliminodiacetic acid) boronic ester (Figure 1)—have been developed, offering improved stability and reactivity in various synthetic applications [3].
Boronic acids are a versatile class of reagents due to their unique properties: they act as mild Lewis acids, exhibit good stability, and are relatively easy to handle. Furthermore, their low toxicity and biodegradability into boric acid make them environmentally friendly and “green” compounds [4].
The acids in question and their esters are known to form from both saturated and unsaturated organic compounds [1]. However, arylboronic acids represent the most prominent class in organic chemistry. Organoboron compounds are widely used in the synthesis of pharmaceuticals, materials, and other valuable molecules. They serve as powerful building blocks in modern organic chemistry, especially in carbon–carbon cross-coupling reactions such as Suzuki–Miyaura, Petasis, Chan–Lam, and Liebeskind–Srogl couplings. Furthermore, organoboron compounds play crucial roles in catalysis, materials science, biology, and imaging [4,5].
Over the past decades, oxadiazoles—classified as five-membered aromatic heterocyclic systems—have attracted considerable scientific interest [6]. Compounds of this type belong to the diazole family and contain two nitrogen atoms and one oxygen atom within their structure. Four isomers of oxadiazoles are known, differing in the relative positions of heteroatoms (Figure 2).
Unlike the unstable 1,2,3-oxadiazoles (Figure 2), sydnones (1,2,3-oxadiazol-3-ium-5-olate) are recognized as their stable derivatives [7]. The other three isomers—1,2,4-oxadiazole, 1,2,5-oxadiazole, and 1,3,4-oxadiazole—are actively being investigated by both medicinal and materials chemists, who are keenly interested in achieving specific properties through optimized substitution patterns. However, 1,3,4-oxadiazole and 1,2,4-oxadiazole are favored by researchers and have been extensively studied for their significant chemical and biological properties (Figure 3).
Derivatives of both 1,2,4- and 1,3,4-oxadiazoles exhibit activity against bacteria, fungi, parasites, and viruses. These compounds are also being explored in research related to anti-inflammatory, anticancer, antidiabetic, antioxidant, and neurological applications [6,8]. The properties of compounds containing 1,2,4- and 1,3,4-oxadiazole strongly depend on the substitution patterns, but some general trends can be recognized. For example, in medicinal chemistry applications, 1,3,4-oxadiazoles demonstrate enhanced properties compared to 1,2,4-oxadiazoles, including an order of magnitude lower lipophilicity (LogD), improved metabolic stability and aqueous solubility, and decreased hERG inhibition [9].
In materials science, 1,3,4-oxadiazoles find primary applications in polymers, particularly in heat-resistant materials, insulators/semiconductors, macromolecular scintillators, and organic light-emitting devices (OLEDs). Their photoluminescent and electrochromic properties, stability, and organosolubility make them valuable as hole-transporting and electrochromic materials, as well as in blue-light-emitting diodes and low-band-gap applications [8]. Furthermore, incorporating electron-deficient 1,3,4-oxadiazole moieties into polymer side chains has been shown to enhance photovoltaic cell efficiency [6]. In contrast, 1,2,4-oxadiazoles are primarily utilized in liquid crystal applications and in emissive materials, where the unsymmetrical atom distribution and electron density within the 1,2,4-oxadiazole ring structure play an important role [8]. Figure 4 illustrates several examples of compounds featuring a 1,3,4-oxadiazole core, with applications across agrochemistry (e.g., Oxadiazone), medicine (e.g., Raltegravir, Zibotentan, Nesapidil), and materials science (e.g., highly conjugated derivatives) [6].
Due to the continuous and growing interest in 1,3,4-oxadiazoles across diverse disciplines, and the significant potential of their boronic acid derivatives for fine-tuning properties in both medicinal chemistry and materials science (Figure 5), a comprehensive review of synthetic approaches is presented. This paper summarizes the achievements since 2000 in synthesizing organoboron derivatives directly or indirectly linked to the 1,3,4-oxadiazole core.

2. General Approaches for the Synthesis of Organoboron Derivatives

The three most popular synthetic approaches to 1,3,4-oxadiazole-containing organoboron derivatives were identified in the literature:
(a)
Halogen–metal–boron exchange in aromatic compounds (method A),
(b)
Miyaura borylation of aryl and vinyl halides using bis(pinacolato)diboron (method B),
(c)
formation of the 1,3,4-oxadiazole ring from acyclic reagents already containing a boronic ester moiety (method C).

2.1. Method A: Lithium/Magnesium–Boron Exchange

One of the earliest and most common methods for synthesizing arylboronic acids involves a three-step sequence, presented in Scheme 1, comprising halogen–metal (lithium or magnesium) exchange in aryl halide, followed by electrophilic trapping with a trialkylborate (typically methyl or isopropyl borate). This reaction is usually performed at low temperatures to minimize over-alkylation, which can lead to the formation of borinic acids (R2B(OH)). The reaction is then quenched with water in an acidic solution to yield the desired boronic acid [10,11,12].

2.2. Method B: Miyaura Borylation

Miyaura borylation is a well-established method for the synthesis of boronic esters, developed by the research group of Norio Miyaura (Scheme 2). It involves the cross-coupling of bis(pinacolato)diboron (B2(pin)2) with aryl or vinyl halides at 80 °C. This method offers several advantages, particularly its mild reaction conditions (e.g., high functional group tolerance, temperature up to 100 °C, without highly reactive organometallic bases), which are beneficial for the preparation of boronic esters that are not accessible through traditional lithium- or Grignard-based borylation approaches. Furthermore, the Miyaura borylation exhibits a broad substrate scope and wide functional group tolerance [13,14].
The role and importance of reaction components in the Miyaura borylation were defined by Miyaura in 1995 and have remained largely unchanged since then. Potassium acetate (AcOK), a weak base, is widely recognized as the optimal choice, providing high yields and selectivity. Employing stronger bases, such as K3PO4 and K2CO3, can lead to side reactions, such as competitive coupling of the boronic ester with the aryl halide, resulting in undesired Suzuki reaction products. The reaction proceeds more rapidly in polar solvents, with DMSO generally exhibiting the highest reactivity, followed by DMF, dioxane, and toluene. Furthermore, Pd(dppf)Cl2 has proven to be the most effective catalyst [13].

2.3. Method C: 1,3,4-Oxadiazole Ring Formation

Another popular approach for the synthesis of 1,3,4-oxadiazole derivatives bearing a boronic acid/ester or MIDA moiety is the formation of the 1,3,4-oxadiazole ring from acyclic starting materials already containing a boronic acid or ester group. The boron-containing group is usually attached to a hydrazine or carboxylic acid reagent. Three of the most popular methods include the cyclization of diacylhydrazides (Scheme 3, method C1) [15], thiosemicarbazides (Scheme 3, method C2) [16], and the oxidative cyclization of acylhydrazones (Scheme 3, method C3) [17].

3. Synthesis of Boronic Derivatives from Reagents Containing 1,3,4-Oxadiazole Moiety

3.1. Direct Connection of Boron with 1,3,4-Oxadiazole Ring

There are relatively few direct methods reported in the literature for synthesizing 1,3,4-oxadiazole boronic derivatives. This is likely due to the inherent challenges associated with introducing a boronic group onto the oxadiazole ring. These challenges arise from the electron-deficient nature of the 1,3,4-oxadiazole ring [6], which makes electrophilic substitution difficult at the C2 and C5 positions. The most common approach involves 2-bromo-1,3,4-oxadiazole as a starting material and proceeds via a two-step process: metal–halogen exchange followed by electrophilic substitution with a trialkylborate (Scheme 4). The first step, bromide–lithium exchange, is performed in the presence of a strong base, n-BuLi, at low temperature (below −40 °C) in an inert solvent such as THF or toluene. The resulting lithium intermediate then reacts with trimethyl or triisopropyl borate to introduce the boronic group. Next, the esters are cleaved under acidic conditions to obtain the boronic acid product (R = H) in yields of 84% [18] and 71% [19].
Another useful boron derivative of oxadiazole is the MIDA boronic ester, which can be prepared via a convenient, one-pot, two-step synthesis from carboxy-MIDA boronic ester and either benzhydrazide or thiosemicarbazide. Subsequent cyclization, mediated by toluenesulfonyl chloride, affords corresponding oxadiazoles in 64% and 56% yield, respectively (Scheme 5A). The carboxy-MIDA boronic ester is synthesized from ethynyl- MIDA boronic ester through oxidation with excess periodic acid, catalyzed by RuCl3·3H2O in MeCN (Scheme 5B) [20]. MIDA boronic esters offer several advantages: they are stable, easily handled, compatible with various reaction conditions, and tolerant of harsh reagents [10].

3.2. Indirect Connection of Boron with 1,3,4-Oxadiazole Ring via Phenylene Linker

1,3,4-Oxadiazole rings linked to boronic derivatives through a benzene ring are common motifs in the synthesis of molecules for OLEDs and biological applications. While meta- and para-substituted compounds are well established, examples of ortho-substituted analogues are less common (Table 1, Figure 6).

3.2.1. Derivatives of Para-Substituted (1,3,4-Oxadiazol-2-yl)phenyl)boronic Acid

Para-phenylene-linked 1,3,4-oxadiazole boronic acids or esters can be synthesized via various methods, starting from the appropriate aryl halides (Scheme 6). Table 2 summarizes the reaction conditions, catalysts, ligands, solvents, and corresponding yields, along with relevant references. Boronic esters can be prepared from aryl halides (X = Cl, Br, I) or pseudohalides (X = OTf) using bis(pinacolato)diboron (B2(pin)2) in the presence of AcOK (method B) [17,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46].
For aryl chlorides used as reactants (Table 2, Entries 1–4), catalyst systems such as Pd(OAc)2 (palladium(II) acetate) with 1,3-bis(2,6-diisopropylphenyl)imidazolium chloride or P(Cy)3 (tricyclohexylphosphine), Pd(dppf)Cl2 (bis(diphenylphosphino)ferrocene)palladium(II) dichloride), or Pd2(dba)3 (tris(dibenzylideneacetone)dipalladium) with 2′-(dicyclohexylphosphino)-N,N-dimethyl [1,1′-biphenyl]-2-amine can be employed in solvents such as THF or 1,4-dioxane to afford the desired para-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol esters in 79–88% yield (Table 2, Entries 1–2).
Bromides are the most commonly used species for Miyaura borylation reactions. Palladium catalysts, particularly Pd(dppf)Cl2 or its DCM adduct, are frequently employed to carry out the coupling reaction. Solvents such as 1,4-dioxane, DMF, or DMSO are typically used, and elevated temperatures are often required to drive the reaction to completion. Yields typically range from 45% to 92% (Table 2, Entries 5–16). In some cases, the addition of copper(I) iodide (CuI) as an additive can improve yields (82%, Table 2, Entry 16).
For aryl iodide substrates, Pd(PPh3)4 (tetrakis(triphenylphosphine)palladium) can be used as a catalyst in 1,4-dioxane at elevated temperatures. However, Bachand et al. reported that the reaction yielded a mixture of boronic acid and ester. To isolate the desired boronic acid, preparative HPLC was necessary, and the yield of the isolated boronic acid was 22% (Table 2, Entry 17).
The Pd(dppf)Cl2 catalyst can be used with aryl triflates. Conducting the reaction in DMF at 95 °C overnight affords the desired boronic ester in 86% yield (Table 2, Entry 18).
Due to potential issues with the isolation and stability of boronic acids and esters during long-term storage, their direct conversion to crystalline trifluoroborate salts can be advantageous (Scheme 7). A two-step, one-pot approach involves the initial formation of boronic acid using the catalytic system XPhos Pd G2 (chloro(2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II)), AcOK, and tetrahydroxydiboron (B2(OH)4) in EtOH at 80 °C for 2 h. After simple extraction, the crude boronic acid is converted to the trifluoroborate salt using an aqueous KHF2 solution. The final product, potassium 4-(1,3,4-oxadiazol-2-yl)phenyltrifluoroborate, is obtained in 34% yield after lyophilization and Soxhlet extraction with acetone [47].
Another common method for synthesizing 1,3,4-oxadiazole–phenylboronic acid derivatives involves a lithium borylation mechanism (Scheme 1, method A). Table 3 summarizes the reaction conditions for this methodology, including the lithium and boron sources, solvents, corresponding yields, and relevant references. The lithium borylation approach most frequently utilizes aryl bromides as starting materials (Scheme 8), which undergo halogen–metal exchange with n-butyllithium (n-BuLi) at low temperatures (from −78 °C to −40 °C) in Et2O (Table 3, Entry 1) or THF (Table 3, Entries 2–7). Trimethyl borate (B(OMe)3) or triisopropyl borate (B(O-i-Pr)3) is then added as a boron source to introduce the boronic ester group. Finally, an acidic workup affords the corresponding 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids. Yields for this method typically range from 42% to 81% (Table 3, Entries 2–5). When isopropylboronic acid pinacol ester is used as the boron source, a six-step lithiation borylation sequence in THF with n-BuLi affords the pinacol boronic ester in 61% overall yield (Table 3, Entry 7).
To improve the efficiency of this approach, a two-step, one-pot procedure has been developed (Table 3, Entries 8a–e). In this method, the starting 2-(4-bromophenyl)-1,3,4-oxadiazole (R1 = H) is initially deprotonated with a weaker base (e.g., MeLi, 4-Li-toluene, 2-Li-toluene, Li-benzene), followed by halogen–metal exchange with a stronger base (e.g., n-BuLi, n-HexLi). Subsequent borylation with trimethyl borate or triisopropyl borate and acidic workup affords the desired 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids in 60–89% yield [53].
The third approach (Scheme 3, method C) involves the formation of the 1,3,4-oxadiazole ring from starting materials already containing a boronic ester moiety (Scheme 9). For example, a pinacol boronic ester can be attached to a carboxylic acid (R1 = OH) or a hydrazide reagent (R2 = NHNH2) via a phenylene linker. Cyclization is achieved using trichloroacetonitrile and triphenylphosphine in acetonitrile at 130 °C under microwave irradiation, followed by hydrolysis of the 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester using ammonium acetate and sodium periodate in an acetone/water mixture or aqueous sulfuric acid (Scheme 9A) [15].
Alternatively, 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester can be reacted with triethyl orthoformate under reflux to form the corresponding 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester in 84% yield. Hydrolysis of the resulting boronic ester with 5% acetic acid affords 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid in 94% yield (Scheme 9B) [16].
Optionally, 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester can be treated with an S-ethylated thioamide in refluxing n-butanol to generate a 1,3,4-oxadiazole ring as a 22% byproduct during triazole synthesis [54]. The structure of this byproduct was confirmed by NMR and X-ray crystallography. Hashemzadeh et al. aimed to obtain boronic acids as ligands for potential luminescent sensors; the synthesized 4-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester was converted into a more stable trifluoroborate potassium salt. This transformation was achieved by treating the boronic ester with potassium hydrogen fluoride (KHF2) in methanol, yielding the desired product in 77%. Subsequent hydrolysis of the trifluoroborate group using lithium hydroxide afforded the 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid derivative in 52% yield (Scheme 9C) [54].
An alternative approach to synthesizing 1,3,4-oxadiazole–phenyl boron derivatives is presented in Scheme 10 and involves the cyclization of N1-benzoylthiosemicarbazide in the presence of EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) in DMSO at 50–60 °C. The final product can be either a [4-(5-amino)-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid derivative (R1 = B(OH)2) or its boronic acid pinacol ester (R1 = B(pin)), depending on the specific functional groups present on the starting material [17].

3.2.2. Derivatives of Meta-Substituted (1,3,4-Oxadiazol-2-yl)phenylboronic Acid

1,3,4-Oxadiazole–phenylboronic acid derivatives bearing a boronic group in the meta position relative to the oxadiazole ring can be synthesized via three methods similar to those used for para-substituted derivatives. Table 4 summarizes the reaction conditions, catalysts, ligands, solvents, and corresponding yields, along with relevant references. The most common approach, based on metal-catalyzed borylation, typically utilizes aryl bromides (X = Br) (Scheme 11, method B). These reactions are usually carried out at elevated temperatures (>90 °C) using bis(pinacolato)diboron (B2(pin)2) as the boron source, potassium acetate (AcOK) as the base, and palladium catalysts such as Pd(dppf)Cl2 or its DCM adduct (Table 4, Entries 1–11). Reactions conducted in 1,4-dioxane afforded the derivatives of 3-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester in yields ranging from 44% to 99% (Table 4, Entries 1–4). Alternatively, the reaction can be performed in DMSO (Table 4, Entries 5–7), although only a single publication reports the yield (62%) for this solvent system (Table 4, Entry 5). Reactions in DMF have yielded 76% (Table 4, Entry 8) and 71% (Table 4, Entry 9), while THF has been used to achieve an 80% yield (Table 4, Entry 10). Additionally, the reaction can be conducted in refluxing dimethoxyethane (Table 4, Entry 11).
A broader range of catalysts can be used for the conversion of 2-(3-bromophenyl)-1,3,4-oxadiazole to meta-substituted 1,3,4-oxadiazole–phenylboronic acid derivatives. For example, Pd(PPh3)2Cl2 (bis(triphenylphosphine)palladium chloride) in 1,4-dioxane can be utilized to obtain the desired product in 35% overall yield over three steps, including hydrazide formation and 1,3,4-oxadiazole ring cyclization (Table 4, Entry 12). Alternatively, the same catalyst can be used in DMSO at 80 °C for 4.5 h to afford the boronic ester in 22% yield (Table 4, Entry 13). As another option, Pd(OAc)2 (palladium(II) acetate) with 2,5-bis(2,6-diisopropylphenyl)imidazolium chloride in refluxing THF gave the desired product in 78–84% yield (Table 4, Entries 14–16).
Aryl iodides can also be used as starting materials. Reactions conducted in the presence of Pd(OAc)2 in DMF at 85 °C for 3 h, or Pd(dppf)Cl2 in DMF at 80 °C for 4 h, led to the formation of 3-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (Table 4, Entries 17–18).
While less common, aryl chlorides can also be employed as substrates. Pd(AcO)2, tricyclohexylphosphine (P(Cy)3), and AcOK in refluxing 1,4-dioxane can convert aryl chlorides to pinacol boronic esters in 79–85% yield (Table 4, Entry 19).
A different synthetic route (method C) involves 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-mediated desulfurative cyclization of the acyl thiosemicarbazide intermediate in a THF/MeOH mixture at 65 °C [73]. This method follows a two-step process involving thiourea formation and carbodiimide-mediated cyclization. The reaction employs 3 equivalents of EDC, with 1.5 equivalents promoting N-acyl-thiosemicarbazide formation and the remaining 1.5 equivalents driving the cyclodesulfurization step. The reaction is completed within 2 h, affording the 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester in 85–91% yield (Scheme 12).
Cyclization of diacyl hydrazide, in particular 3-(2-acylhydrazinecarbonyl)phenylboronic acid pinacol ester, can be achieved using tosyl chloride as a dehydrating agent in the presence of N,N-diisopropylethylamine (DIPEA). The reaction can be carried out in dichloromethane at room temperature to yield the 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester in 77% yield [74], or in acetonitrile at 40 °C to afford the product in 62% yield (Scheme 13) [67].
The third approach to synthesizing meta-substituted phenylboronic acid derivatives of 1,3,4-oxadiazole is the metal–halogen exchange reaction (method A). Commonly, 2-(3-bromophenyl)-1,3,4-oxadiazole derivatives are used as starting materials and reacted with n-BuLi as a strong base and triisopropyl borate (B(O-i-Pr)3) as the boron source at −78 °C in dry THF. Subsequent acidic hydrolysis of the resulting boronic esters yields the desired 3-(1,3,4-oxadiazol-2-yl)phenylboronic acids in 60–80% yield [69,75]. A similar method can be applied for bis-meta-bromo substitution using trimethyl borate (B(OMe)3) (Scheme 14) [76].
Alternatively, meta-iodophenyl derivatives such as 2-(3-iodophenyl)-1,3,4-oxadiazole can be employed to form Grignard reagents (Scheme 14). Isopropylmagnesium chloride (i-PrMgCl) can be used for metal–halogen exchange, followed by substitution with triisopropyl borate. Subsequent acidic hydrolysis leads to meta-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester derivatives in 37–66% yield. The reaction is typically carried out in THF under milder conditions (−10 °C) compared to the lithium-based approach [77,78,79].

3.2.3. Derivatives of Ortho-Substituted (1,3,4-Oxadiazol-2-yl)phenylboronic Acid

The 2-(1,3,4-oxadiazol-2-yl)phenylboronic acid or its pinacol ester derivative can be obtained via three approaches (methods A, B, and C). The first, method A, involves a lithiation borylation sequence of 2-(2-bromophenyl)-1,3,4-oxadiazole derivatives using n-BuLi and triisopropyl borate in a toluene/THF mixture at −78 °C, followed by acidic hydrolysis (Scheme 15) [15].
An alternative method involves the Miyaura borylation reaction (Scheme 15, method B). (2-Bromophenyl)-1,3,4-oxadiazole intermediate can be coupled with bis(pinacolato)diboron using Pd(dppf)2Cl2 as a catalyst, AcOK as a base, and DMSO as a solvent at 80 °C for 2–8 h. The resulting 2-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester can then be hydrolyzed using 0.2M sulfuric acid to yield 2-(1,3,4-oxadiazol-2-yl)phenylboronic acid [15]. (2-Chlorophenyl)-1,3,4-oxadiazoles can also be used as substrates in Miyaura borylation reactions. These reactions typically utilize Pd(OAc)2 as the catalyst, AcOK as the base, and tricyclohexylphosphine as the ligand. Refluxing the reaction mixture in 1,4-dioxane for 2 h affords the pinacol boronic ester in 75–86% yield [21].
A third strategy involves the formation of the 1,3,4-oxadiazole ring from a precursor containing a boronic ester group (Scheme 16, method C). The derivatives of benzhydrazide or benzoic acid bearing a boronic ester group can be cyclized using trichloroacetonitrile and triphenylphosphine in acetonitrile at 130 °C. Subsequent hydrolysis of 2-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester with ammonium acetate and sodium periodate in an acetone/water mixture affords the desired boronic acid [15].

3.3. Indirect Connection of Boron with 1,3,4-Oxadiazole Ring via Heterocyclic Linker

Beyond phenyl derivatives, the linkers connecting 1,3,4-oxadiazole and boronic acid units also include a diverse range of heteroaromatic compounds. A literature review demonstrates that, among heterocyclic linker-containing scaffolds, pyridine derivatives are the most commonly reported (48%), followed by indoles (24%) and thiophene rings (12%) (Figure 7).

3.3.1. Boronic Acid Derivatives of (1,3,4-Oxadiazol-2-yl)pyridines

The pyridine ring is one of the most important heteroaromatic rings, present in many organic compounds with a wide range of applications in pharmaceuticals and agrochemicals, and is also found in certain vitamins such as B6 and B3 [80,81,82,83].
The pyridine ring attached to the 1,3,4-oxadiazole ring was functionalized with boronic esters or acids at four possible positions (Figure 8). For clarity, boronic acids/esters located at the 6-position relative to the nitrogen (6-(1,3,4-oxadiazol-2-yl)pyridin-2-ylboronic acid (65)) atom are referred to as 2-pyridinylboronic acids, while those at the 5-position (5-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (66)) are classified as 3-pyridinylboronic acids, based on their nitrogen–boron positional relationship.
There are limited reported syntheses of 1,3,4-oxadiazol-2-ylpyridine boronic acid derivatives. This is likely due to the instability of 2-pyridinyl boronic acids, which readily undergo protodeboronation [84]. To improve their stability, strategies such as the use of alternative boronate species—including N-methyliminodiacetic acid (MIDA) boronates and N-phenyldiethanolamine (PDEA) boronates—one-pot or in situ generation, or the addition of copper salts as stabilizing agents are commonly employed [84]. However, these methods have not yet been reported for the synthesis and stabilization of 1,3,4-oxadiazol-2-ylpyridine boronic acid derivatives. 2-Pyridinylboronic esters, however, are much more stable than the corresponding acids [85]. One method (Scheme 17) describes the successful Miyaura borylation (method B) of a 1,3-bis(5-(6-bromopyridin-2-yl)-1,3,4-oxadiazol-2-yl)benzene to form the desired 6,6′-(5,5′-(1,3-phenylene)bis(1,3,4-oxadiazole-5,2-diyl))bis(pyridine-6,2-diyl)diboronic acid dipinacol ester in 81% yield. This approach utilizes bis(pinacolato)diboron (B2(pin)2) as the boron source, tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) as the catalyst, and AcOK as the base in 1,4-dioxane at 110 °C [86,87].
Several studies focus on the synthesis of 1,3,4-oxadiazole–pyridine derivatives bearing a boron atom at the 3-position relative to the pyridinyl nitrogen (Figure 9) [69,88,89,90,91]. Two general approaches have been employed: Miyaura borylation (method B) and halogen–metal exchange via lithiation (method A). Table 5 summarizes the reaction conditions, catalysts, solvents, bases, and the corresponding yields, together with relevant references. The Miyaura borylation protocol involves the cross-coupling of 3-bromopicolic acid derivatives with bis(pinacolato)diboron (B2(pin)2). Common catalysts for this reaction leading to derivative 5-(1,3,4-oxadiazol-2-yl)-pyridin-3-ylboronic acid pinacol ester include Pd(dppf)Cl2 (bis(diphenylphosphino)ferrocene)palladium(II) dichloride) or its DCM adduct. Solvents such as DMSO, acetonitrile, or 1,4-dioxane are typically used in conjunction with potassium acetate as the base (Table 5, Entries 1–3). Microwave irradiation can accelerate the reaction in some cases (Table 5, Entries 1–2). However, yield data are often absent from the literature. One notable exception reports a 15% yield for a reaction conducted in DMSO at 80 °C (Table 5, Entry 3). For 4-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester, the synthesis involves PdCl2(PPh3)2 (bis(triphenylphosphine)palladium(II) dichloride), potassium acetate, and triethylamine in 1,4-dioxane at 100 °C, yielding the boronic ester in 76% yield (Table 5, Entry 4). A single example describes a 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester, synthesized using Pd(dppf)Cl2·DCM and potassium acetate in DMSO at 80 °C. A 35% yield was obtained after 2 h of heating and standard workup (Table 5, Entry 5).
The second method for preparing boronic acids linked to a 1,3,4-oxadiazole ring via a pyridine moiety is based on a lithium borylation mechanism (method A). This method, applicable to 5-bromo-2-(1,3,4-oxadiazol-2-yl)pyridine, employs n-butyllithium in hexane and triisopropyl borate (B(O-i-Pr)3) (Scheme 18). The reaction is conducted in THF or a 4:1 mixture of toluene and THF at –78 °C. The reaction can be quenched with water, followed by boronic ester hydrolysis using 50% HCl and subsequent boronic acid precipitation. Alternatively, quenching with 2N aqueous HCl, extraction, and crystallization can be employed to isolate the 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid [15].

3.3.2. Boronic Acid Derivatives of 1,3,4-Oxadiazol-2-yl-indoles

Indole, a bicyclic aromatic heterocyclic compound, is a fundamental scaffold found in numerous natural products, pharmaceuticals, and materials science [92,93,94]. Its unique structural features, including a fused benzene and pyrrole ring, provide diverse opportunities for chemical modification.
The indole ring is typically connected to a 1,3,4-oxadiazole at position 6, 5, or 7 of the bicyclic heterocycle (Figure 10). It is worth noting that all reported compounds contain a protected indolyl nitrogen atom, commonly using protecting groups such as SEM (2-(trimethylsilyl)ethoxymethyl), Boc (tert-butoxycarbonyl), or Ts (tosyl), which can be easily removed in later stages of synthesis. The boronic acid or ester groups are attached at position 2 or position 3 of the indole ring. Depending on the point of attachment, different synthetic approaches have been reported [95,96,97,98,99].
For the 2-position of the indole ring, a C–H activation approach starting from 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indole has been reported (Scheme 19). The reaction utilizes lithium diisopropylamide (LDA) and triisopropyl borate (B(O-i-Pr)3) in dry THF at 0 °C, yielding the corresponding 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indol-2-ylboronic acid in 47% [95,96].
To introduce a boronic group at the 3-position of the indole ring, a halogen–metal exchange reaction is commonly employed (method A). This involves reacting 3-iodo-1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indole with bis(pinacolato)diboron (B2(pin)2), Pd(dppf)Cl2 (bis(diphenylphosphino)ferrocene)palladium(II) dichloride), and potassium acetate (AcOK) in DMF at 90 °C for 1 h (Scheme 20). The resulting crude mixture of 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid and its pinacol ester can be used directly in Suzuki coupling reactions, affording yields of 19–54% [97,98]. Alternatively, when the starting material contains a bromine atom (e.g., 1-SEM-3-bromo-7-(1,3,4-oxadiazol-2-yl)indole), the reaction is conducted in 1,4-dioxane at 80 °C overnight, followed by purification via reverse-phase column chromatography, yielding 1-SEM-7-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid in 14% [99].

3.3.3. Boronic Acid Derivatives of 1,3,4-Oxadiazol-2-yl-thiophenes, 1,3,4-Oxadiazol-2-yl-furan and 1,3,4-Oxadiazol-2-yl-ethenyl Derivatives

Thiophene and furan are five-membered heteroaromatic rings containing a sulfur or oxygen atom, respectively. Their unique electronic, optical, and structural properties make them valuable building blocks in medicinal chemistry [100,101], agrochemistry [102], and materials science [103,104,105].
Two primary approaches have been reported for synthesizing thiophene-linked 1,3,4-oxadiazoles (Figure 11). The first involves a halogen–metal exchange strategy (method A), employing 2.4M n-BuLi in hexane and isopropyl pinacol borate in THF at −78 °C to synthesize symmetrical 5,5′-(1,3,4-oxadiazole-2,5-diyl)bis(thiophene-5,2-diyl)diboronic acid dipinacol ester. The product is obtained in 22% yield after extraction and purification by column chromatography [25].
The second approach is based on the formation of a 1,3,4-oxadiazole ring from a carboxythiophene boronic ester and an appropriate hydrazide (method B). This reaction is carried out in the presence of polystyrene-supported triphenylphosphine (PPh3) and trichloroacetonitrile in dry acetonitrile under microwave irradiation at 130 °C for 2 h. The resulting thienyl boronic ester (with the boron atom at the 2- or 3-position relative to the sulfur atom) is subsequently converted to the corresponding boronic acids: 5-(1,3,4-oxadiazol-2-yl)thiophen-3-ylboronic acid (84), 5-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (85), 3-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (86) using sodium periodate and ammonium acetate in an acetone/water mixture. The boronic acid can be isolated using various methods, including precipitation with 1N HCl, extraction, recrystallization, trituration, or flash column chromatography. This approach has also been successfully applied to the derivatives containing furan and ethenylbenzene linkers such as 4-(1,3,4-oxadiazol-2-yl)furan-2-ylboronic acid and 2-(2-(5-methyl-1,3,4-oxadiazol-2-yl)vinyl)phenylboronic acid (Figure 11) [15].

3.3.4. Other Boronic Acid Derivatives of 1,3,4-Oxadiazole Substituted with Dibenzothiophene, Dibenzofuran, Naphthalene, and Biphenyl

Dibenzo[b,d]furan and dibenzothiophene have also been used as heterocyclic linkers between 1,3,4-oxadiazole and boronic esters [21,31,32]. These compounds were synthesized via Miyaura borylation of the corresponding chloro derivatives using bis(pinacolato)diboron (B2(pin)2), potassium acetate (AcOK) as the base, palladium(II) acetate (Pd(OAc)2) as the catalyst, and tricyclohexylphosphine (P(Cy)3) as the ligand. The reactions were conducted in refluxing 1,4-dioxane, yielding the desired products containing dibenzofuran and dibenzothiophene linkers in 85% and 71% yields (Figure 12). The same approach was also applied to naphthalene and biphenyl linkers [21]. Boronic esters of biphenyl derivatives of 1,3,4-oxadiazole: 4′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-4-ylboronic acid pinacol ester and 3′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-2-ylboronic acid pinacol ester (Figure 12) were synthesized in 90% [32] and 59% [31] yields, respectively. The reactions were conducted in 1,4-dioxane in the presence of bis(diphenylphosphino)ferrocene)palladium(II) dichloride (Pd(dppf)Cl2) and potassium acetate (AcOK).

4. Conclusions

This review focuses on effective methods for preparing boronic acids and their derivatives conjugated with 1,3,4-oxadiazole scaffolds, either directly or via a linker. The three most frequently reported synthetic approaches in the literature were highlighted, utilizing a broad spectrum of available reagents. Their key features are summarized in Table 6.
For instance, halogens or pseudo-halogens can be strategically employed in well-established reactions such as metal–boron exchange (method A) or Miyaura borylation (method B). Meanwhile, carboxylic acids or their derivatives play a key role in the cyclization process that forms the 1,3,4-oxadiazole ring itself (method C). These synthetic strategies enable the formation of 1,3,4-oxadiazole-containing boronic derivatives, which are powerful tools with significant potential applications across various fields, such as optoelectronics (e.g., OLEDs, semiconductors), luminescent and fluorescent chemosensors, and advanced polymers. In biological contexts, they show promise for bioimaging and targeted drug delivery (e.g., in oncology and the central nervous system (CNS)). The versatility of these boron reagents allows for further derivatization and broad diversification of 1,3,4-oxadiazole-based cores. The resulting strategies demonstrate significant potential across various scientific disciplines, including medicinal chemistry (e.g., as drug candidates with diverse pharmacological activities), agrochemistry (e.g., as herbicides, insecticides, and fungicides), and materials science (e.g., in optoelectronic applications and advanced polymers). Ongoing investigation of these boronic acid derivatives of 1,3,4-oxadiazoles is accelerating the discovery and development of next-generation oxadiazole-based compounds with tailored properties and expanded utility, opening doors to future innovations.

Author Contributions

B.W. and A.K. contributed their ideas related to concept design, data collection, manuscript preparation, language editing, and revision. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

Author Barbara Wołek was employed by the company Selvita S.A. Selvita S.A. had no influence on the selection, design, or interpretation of the topics discussed. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Hosmane, N.S. (Ed.) Boron Science: New Technologies and Applications, 1st ed.; CRC Press: Boca Raton, FL, USA, 2012. [Google Scholar] [CrossRef]
  2. Perkins, G.L. Boron: Compounds, Production and Application, UK ed.; NOVA Science Publishers, Inc.: Hauppauge, NY, USA, 2011. [Google Scholar]
  3. Qiao, H.; Michalland, J.; Huang, Q.; Zard, S.Z. A Versatile Route to Acyl (MIDA)boronates. Chem. Eur. J. 2023, 29, e202302235. [Google Scholar] [CrossRef] [PubMed]
  4. Hall, D.G. Structure, Properties, and Preparation of Boronic Acid Derivatives: Overview of Their Reactions and Applications. In Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials, 2nd ed.; Hall, D., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2011; pp. 1–133. [Google Scholar] [CrossRef]
  5. Hiller, N.J.; do Amaral e Silva, N.A.; Tavares, T.A.; Faria, R.X.; Eberlin, M.N.; de Luna Martins, D. Arylboronic Acids and their Myriad of Applications Beyond Organic Synthesis. Eur. J. Org. Chem. 2020, 2020, 4841–4877. [Google Scholar] [CrossRef]
  6. Walczak, K.Z.; Szczepankiewicz, W. 1,3,4-Oxadiazoles. In Comprehensive Heterocyclic Chemistry IV, 1st ed.; Black, D., Cossy, J., Stevens, C., Eds.; Elsevier: Oxford, UK, 2022; Volume 5, pp. 252–317. [Google Scholar] [CrossRef]
  7. Joule, J.A.; Mills, K. Heterocycles Containing More Than Two Heteroatoms. In Heterocyclic Chemistry, 5th ed.; Joule, J., Mills, K., Eds.; Wiley-Blackwell, John Wiley & Sons Ltd.: Hoboken, NJ, USA, 2010; pp. 569–574. [Google Scholar]
  8. Piccionello, A.P.; Pibiri, A.; Pace, A.; Buscemi, S.; Vivona, N. 1, 2, 4-Oxadiazoles. In Comprehensive Heterocyclic Chemistry IV, 1st ed.; Black, D., Cossy, J., Stevens, C., Eds.; Elsevier: Oxford, UK, 2022; Volume 5, pp. 147–189. [Google Scholar] [CrossRef]
  9. Bostrom, J.; Hogner, A.; Llinas, A.; Wellner, E.; Plowright, A.T. Oxadiazoles in Medicinal Chemistry. J. Med. Chem. 2012, 55, 1817–1830. [Google Scholar] [CrossRef] [PubMed]
  10. Lennox, A.J.J.; Lloyd-Jones, G.C. Selection of boron reagents for Suzuki–Miyaura coupling. Chem. Soc. Rev. 2014, 43, 412–443. [Google Scholar] [CrossRef] [PubMed]
  11. Boyet, M.; Chabaud, L.; Pucheault, M. Recent Advances in the Synthesis of Borinic Acid Derivatives. Molecules 2023, 28, 2660. [Google Scholar] [CrossRef] [PubMed]
  12. Silva, M.P.; Saraiva, L.; Pinto, M.; Sousa, M.E. Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. Molecules 2020, 25, 4323. [Google Scholar] [CrossRef] [PubMed]
  13. Ishiyama, T.; Murata, M.; Miyaura, N. Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters. J. Org. Chem. 1995, 60, 7508–7510. [Google Scholar] [CrossRef]
  14. Ishiyama, T.; Ishida, K.; Miyaura, N. Synthesis of pinacol arylboronates via cross-coupling reaction of bis(pinacolato)diboron with chloroarenes catalyzed by palladium(0)–tricyclohexylphosphine complexes. Tetrahedron 2001, 57, 9813–9816. [Google Scholar] [CrossRef]
  15. Behnke, M.L.; Castro, A.C.; Evans, C.A.; Grenier, L.; Grogan, M.J.; Liu, T.; Snyder, D.A.; Tibbitts, T.T. Preparation of Oxadiazolylphenylboronic Acid Derivatives and Analogs for Use as Fatty Acid Amide Hydrolase Inhibitors. WO 2009126691 A1, 15 October 2009. [Google Scholar]
  16. Vollmueller, F.; Haber, S.; Meudt, A.; Noerenberg, A.; Scherer, S. Preparation of p-Oxadiazolylphenylboronic Acids. DE 19857765 A1, 21 June 2000. [Google Scholar]
  17. Jeong, B.S.; Kim, J.A.; Chang, J.H.; Nam, T.G. Preparation of 6-Heteroarylamino-2,4,5-Trimethylpyridin-3-ol Derivatives for Prevention or Treatment of Inflam Matory Bowel Diseases and Autoimmune Diseases. WO 2019194556 A1, 10 October 2019. [Google Scholar]
  18. Zhou, W.; Cai, H. Aromatic Compound and Organic Electroluminescent Device Thereof. CN 108976177 A, 11 December 2018. [Google Scholar]
  19. Kim, G.T.; Ahn, H.C.; Ham, H.W.; Kim, D.J.; Han, J.U. Preparation of Organic Light Emitting Compound Substituted with Deuterium. KR 2014091496 A, 21 July 2014. [Google Scholar]
  20. Holownia, A.; Tien, C.-H.; Diaz, D.B.; Larson, R.T.; Yudin, A.K. Carboxyboronate: A Versatile C1 Building Block. Angew. Chem. Int. Ed. 2019, 58, 15148–15153. [Google Scholar] [CrossRef] [PubMed]
  21. Ha, J.S.; Heo, J.O.; Heo, D.U.; Kim, S.S.; Chun, M.S.; Cho, H.M. Preparation of Aromatic Heterocyclic Compound for Organic Light-Emitting Device. KR2021004849 A, 13 January 2021. [Google Scholar]
  22. Steeneck, C.; Kinzel, O.; Gege, C.; Kleymann, G.; Hoffmann, T. Preparation of Pyrrolocarboxamides as Modulators of Orphan Nuclear Receptor R AR-Related Orphan Receptor-Gamma (RORγ, NR1F3) Activity and for the Treatment of Chronic Inflammatory and Autoimmune Diseases. WO 2013079223 A1, 6 June 2013. [Google Scholar]
  23. Hasvold, L.A.; Hexamer, L.; Li, G.; Lin, N.-H.; Sham, H.; Sowin, T.J.; Sullivan, G.M.; Wang, L.; Xia, P. Preparation of Dibenzo [b,e][1,4]Diazepin-11-Ones as Kinase Inhibitors for Treatment of Cancer. US 20070254867 A1, 11 November 2007. [Google Scholar]
  24. Wołek, B.; Werłos, M.; Komander, M.; Kudelko, A. Efficient Synthesis of Novel 1,3,4-Oxadiazoles Bearing a 4-N,N-Dimethylaminoquinazoline Scaffold via Palladium-Catalyzed Suzuki Cross-Coupling Reactions. Molecules 2020, 25, 5150–5168. [Google Scholar] [CrossRef] [PubMed]
  25. Lee, T.; Landis, C.A.; Dhar, B.M.; Jung, B.J.; Sun, J.; Sarjeant, A.; Lee, J.-H.; Katz, H.E. Synthesis, Structural Characterization, and Unusual Field-Effect Behavior of Organic Transistor Semiconductor Oligomers: Inferiority of Oxadiazole Compared with Other Electron-Withdrawing Subunits. J. Am. Chem. Soc. 2009, 131, 1692–1705. [Google Scholar] [CrossRef] [PubMed]
  26. Hao, Z.; Li, M.; Liu, Y.; Wang, Y.; Xie, G.; Liu, Y. Near-infrared emission of dinuclear iridium complexes with hole/electron transporting bridging and their monomer in solutionprocessed organic light-emitting diodes. Dyes Pigm. 2018, 149, 315–322. [Google Scholar] [CrossRef]
  27. Luzzio, M.; Lucas, B. Preparation of Substituted Thiadiazoles as Small Molecule Splicing Modulator Compounds for Modulating Splicing of mRNA. WO 2020163323 A1, 13 August 2020. [Google Scholar]
  28. Luzzio, M.; Lucas, B. Preparation of Substituted Pyridazines as small Molecule Splicing Modulator Compounds for Modulating Splicing of mRNA. WO 2020163647 A1, 13 August 2020. [Google Scholar]
  29. Moon, H.-S.; Yoo, M.-H.; Kim, S.-H.; Lim, J.-I.; Son, M.-H.; Kim, M.-K.; Shin, C.-Y.; Kim, J.-K.; Park, S.-K.; Chae, Y.-N.; et al. Novel Phenylpropionic Acid Derivatives as Peroxisome Proliferator-Activated Gamma Receptor Modulators, Method of Preparing the Same, and Pharmaceutical Composition Comprising the Same. WO 2008108602 A1, 12 September 2008. [Google Scholar]
  30. Chatterjee, A.K.; Nagle, A.S.; Paraselli, P.; Leong, S.Y.; Roland, J.T.; Mishra, P.K.; Yeung, B.K.S.; Zou, B. Preparation of Imidazopyrazines for Treating Parasitic Diseases. WO 2014078813 A1, 22 May 2014. [Google Scholar]
  31. Grenz, D.C.; Rose, D.; Wossner, J.S.; Wilbuer, J.; Adler, F.; Hermann, M.; Chan, C.-Y.; Adachi, C.; Esser, B. Spiroconjugated Tetraaminospirenes as Donors in Color-Tunable Charge-Transfer Emitters with Donor-Acceptor Structure. Chem. Eur. J. 2022, 28, 202104150. [Google Scholar] [CrossRef] [PubMed]
  32. Guo, L.; Liu, X.; Zhang, T.; Luo, H.-B.; Fan, H.H.; Wong, M.S. Star-shaped triazine-cored ladder-type ter(p-phenylene)s for high-performance multiphoton absorption and amplified spontaneous blue emission. J. Mater. Chem. C 2020, 8, 1768–1772. [Google Scholar] [CrossRef]
  33. Breslin, M.J.; Fraley, M.E.; Loughran, H.M.; Mulhearn, J.J.; Roecker, A.J.; Schirripa, K.M.; Stachel, S.J. Preparation of Modified Isoindolinones as Glucosylceramide Synthase Inhibitors. WO 2022115301 A1, 6 June 2022. [Google Scholar]
  34. Park, J.G.; Choi, Y.H.; Lee, B.S.; Moon, S.Y.; Hwang, S.P.; Park, H.G.; Cho, H.M.; Lee, D.W. Preparation of Organic Electronic Device Materials. KR2014094408 A, 30 July 2014. [Google Scholar]
  35. Linton, K.E.; Fisher, A.L.; Pearson, C.; Fox, M.A.; Palsson, L.-O.; Bryce, M.R.; Petty, M.C. Colour tuning of blue electrolumi-nescence using bipolar carbazole–oxadiazole molecules in single-active-layer organic light emitting devices (OLEDs). J. Mater. Chem. 2012, 22, 11816–11825. [Google Scholar] [CrossRef]
  36. McCoull, W.; Boyd, S.; Brown, M.R.; Coen, M.; Collingwood, O.; Davies, N.L.; Doherty, A.; Fairley, G.; Goldberg, K.; Hardaker, E.; et al. Optimization of an Imidazo [1,2-a] pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy. J. Med. Chem. 2021, 64, 13524–13539. [Google Scholar] [CrossRef] [PubMed]
  37. Liu, Y.; Chen, K.; Xing, K.; Wang, Y.; Jiang, H.; Deng, X.; Zhu, M.; Zhu, W. Conjugated and nonconjugated bipolar-transporting dinuclear europium(III) complexes involving triphenylamine and oxadiazole units: Synthesis, photophysical and electroluminescent properties. Tetrahedron 2013, 69, 4679–4686. [Google Scholar] [CrossRef]
  38. Hiyoshi, H.; Aoyama, T.; Wada, T.; Sonoda, T.; Mataka, S. Synthesis and properties of disk-shaped bipolar symmetric cyclic triindole derivative. Heterocycles 2009, 77, 595–602. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, F.; Lei, P.; Sohail, A.; Ablajan, K. I2-Mediated Synthesis of 1,3,4-Oxa/thiadiazoles from Aroylhydrazide and Acetonitrile/Thioacetamide. J. Org. Chem. 2024, 89, 15490–15496. [Google Scholar] [CrossRef] [PubMed]
  40. Mallinger, A.; Crumpler, S.; Pichowicz, M.; Waalboer, D.; Stubbs, M.; Adeniji-Popoola, O.; Wood, B.; Smith, E.; Thai, C.; Henley, A.T.; et al. Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen. J. Med. Chem. 2015, 58, 1717–1735. [Google Scholar] [CrossRef] [PubMed]
  41. Buckman, B.O.; Nicholas, J.B.; Emayan, K.; Seiwert, S.D.; Yuan, S. N-Heteroaryl Carbamates as Lysophosphatidic Acid Receptor Antagonists and their Preparation. WO 2014113485 A1, 24 July 2014. [Google Scholar]
  42. Xue, S.; Wang, R.; Li, T.; Sun, Q.; Yang, W. Preparation of Compounds with Fluorene as Core and its Application in Organic Electroluminescent Devices. WO 2023070700 A1, 4 May 2023. [Google Scholar]
  43. Jung, H.-G.; Kang, U.-S.; Park, J.-S.; Kim, N.-S.; In, K.-Y.; Kang, E.-S.; Chae, M.-Y. Novel Compound for Organic Photoelectric Device and Organic Photoelectric Device Including the Same. WO 2009051454 A2, 23 April 2009. [Google Scholar]
  44. Feng, J.; Zhao, L.; He, L.; Tang, Y.; Di, Q.; Zhang, H.; Bian, K.; Liu, D. Preparation of Oxadiazole Based Heterocyclic Compound and its Application in OLED. CN 116023374 A, 28 April 2023. [Google Scholar]
  45. Bachand, C.; Belema, M.; Deon, D.H.; Good, A.C.; Goodrich, J.; Hamann, L.G.; James, C.A.; Langley, D.R.; Lavoie, R.; Lopez, O.D.; et al. Preparation of Biphenyls and Biheteroaryls End-Capped with Amino Acid or Peptide Derivatives as Hepatitis C Virus Inhibitors. WO 2008144380 A1, 11 November 2008. [Google Scholar]
  46. Flynn, D.L.; Kaufman, M.D.; Patt, W.C.; Petillo, P.A. Preparation of Heterocyclic Ureas as Kinase Inhibitors Useful for the Treatment of Prolife Rative and Inflammatory Diseases. WO 2008034008 A2, 20 March 2008. [Google Scholar]
  47. Molander, G.A.; Trice, S.L.J.; Kennedy, S.M.; Dreher, S.D.; Tudge, M.T. Scope of the Palladium-Catalyzed Aryl Borylation Utilizing Bis-Boronic Acid. J. Am. Chem. Soc. 2012, 134, 11667–11673. [Google Scholar] [CrossRef] [PubMed]
  48. Xu, Q.; Li, H.; Zheng, Y.; Zuo, J.; You, X. Oxadiazolyl-Containing Green Ir(III) Complex, its Preparation Process and Application. CN 102659773 A, 12 September 2012. [Google Scholar]
  49. Xu, Q.; Li, H.; Zheng, Y.; Zuo, J.; You, X. Preparation Method of Red-Emitting Iridium(III) Complexes with Oxadiazole Group. CN 102875542 A, 16 January 2013. [Google Scholar]
  50. Xu, Q.-L.; Li, H.-Y.; Wang, C.-C.; Zhang, S.; Li, T.-Y.; Jing, Y.-M.; Zheng, Y.-X.; Huang, W.; Zuo, J.-L.; You, X.-Z. Synthesis, structure, photophysical and electrochemical properties of series of new fac-triscyclometallated iridium complexes with carbazole or oxadiazole moieties. Inorg. Chim. Acta 2012, 391, 50–57. [Google Scholar] [CrossRef]
  51. Zhang, T.; Zhu, C.; Ma, Y.; Wang, C.; Shen, Y. Synthesis, Structure and Photophysical Properties of Silole-Oxadiazole Copolymers. Chin. J. Chem. 2013, 31, 779–786. [Google Scholar] [CrossRef]
  52. Qin, Z.; Tan, H.; Zhu, W. Study on influence of end group on photoelectric performance of polyfluorene derivatives containing D-A structure and red phosphorescent group. Nat. Sci. J. Xiangtan Univ. 2012, 34, 65–71. [Google Scholar]
  53. Butlin, M.A.; Butlin, R.J.; Hogan, P.J.; Meudt, A. Chemical Process in Preparation of Oxadiazolylphenylboronic Acid Used in Preparation of Pyrazinyl Oxadiazolyl Pyridine Sulfonamide Endothelin Receptor. WO 2005080403 A2, 1 September 2005. [Google Scholar]
  54. Hashemzadeh, T.; Haghighatbin, M.A.; Agugiaro, J.; Wilson, D.J.D.; Hogan, C.F.; Barnard, P.J. Luminescent iridium(iii)–boronic acid complexes for carbohydrate sensing. Dalton Trans. 2020, 49, 11361–11374. [Google Scholar] [CrossRef] [PubMed]
  55. Erra Sola, M.; Carrascal Riera, M.; Taltavull Moll, J.; Caturla Javaloyes, J.F.; Bernal Anchuela, F.J.; Pages Santacana, L.M.; Mir Cepeda, M.; Casals Coll, G.; Hernandez Olasagarre, M.B. Pyrrolotriazinone Derivatives as PI3K Inhibitors and their Prepar Ation. WO 2014060432 A1, 24 April 2014. [Google Scholar]
  56. Zhang, H.; Zhou, J.; Zhao, T.; Zhu, P.; Xie, L.; Zhang, J. Preparation of Heterocyclic Substituted Biphenyl Compounds and its Application in Preparation of Medicament for Treatment of Diseases Mediated by PD-1/PD-L1. CN 116730940 A, 12 September 2023. [Google Scholar]
  57. Yang, X.; Cui, R.; Yin, J.; Zheng, M.; Chen, N.; Lv, Y. Preparation of Imidazopyridazine Derivatives and Application as PIM Kinase Inhibitor. CN 114409656 A, 29 April 2022. [Google Scholar]
  58. Zhu, M.; Wang, Q.; Gu, Y.; Cao, X.; Zhong, C.; Ma, D.; Qina, J.; Yang, C. Efficient deep-blue emitters comprised of an anthracene core and terminal bifunctional groups for nondoped electroluminescence. J. Mater. Chem. 2011, 21, 6409–6415. [Google Scholar] [CrossRef]
  59. Castro Palomino Laria, J.C.; Terricabras Belart, E.; Erra Sola, M.; Navarro Romero, E.; Fonquerna Pou, S.; Cardus Figueras, A.; Lozoya Toribio, M.E. Azabiphenylaminobenzoic Acid Derivatives as Dhodh Inhibitors. WO 2009021696 A1, 19 February 2009. [Google Scholar]
  60. Wu, W.-L.; Burnett, D.A.; Stamford, A.; Cumming, J.N.; Asberom, T.; Bennett, C.; Sasiskumar, T.K.; Scott, J.D. Preparation of Spiroiminothiazine Derivatives for Use as BACE Inhibitors. WO 2013028670 A1, 28 February 2013. [Google Scholar]
  61. Gilbert, E.J.; Cumming, J.N.; Stamford, A.W.; Yu, Y.; Scott, J.D.; Iserloh, U.; Wang, L.; Caldwell, J.P. Preparation of Tricyclic Substituted Thiadiazine Dioxide Compounds as BACE Inhibitors, Compositions, and their Therapeutic Use. WO 2014062553 A1, 24 April 2014. [Google Scholar]
  62. Bentsen, J.G.; Goplen, N.P.; Li, Y.; Roberts, R.R. Electron Transport Agents for Organic Electronic Devices. US 20040214036 A1, 28 October 2004. [Google Scholar]
  63. Fan, T.-H.; Chen, Y. Solution-processable bipolar host materials composed of fluorenyl, carbazolyl and 1,3,4-oxadiazolyl derivatives: Synthesis and application in phosphorescent organic light-emitting diodes. J. Mater. Chem. C 2016, 4, 5091–5101. [Google Scholar] [CrossRef]
  64. Wang, G.-C.; Lin, S.-W.; Hong, W.-Y.; Fang, G.-C.; Zheng, S.-X. Electron Transmission Material and Organic Light-Emitting Element. TWI 501959 B, 10 October 2015. [Google Scholar]
  65. Miwatashi, S.; Kaieda, A.; Takahashi, M.; Inui, H.; Okamoto, R. Preparation of Fused Heterocyclic Compounds as p38 M AP Kinase Inhibitors and Inhibitors of TNF-α Production. WO 2011021678 A1, 24 February 2011. [Google Scholar]
  66. Ito, M.; Yamamoto, T.; Kakegawa, K.; Sugiyama, H.; Miyazaki, T.; Arikawa, Y.; Okawa, T.; Yonemori, J.; Kubo, O.; Toita, A.; et al. Heterocyclic Compound Having Histone Deacetylase Inhibiting Activity, and Pharmaceutical Composition. WO 2020158762 A1, 6 August 2020. [Google Scholar]
  67. Liu, S.; Wu, Q.; Zhang, T.; Zhang, H.; Han, J. Supramolecular brush polymers prepared from 1,3,4-oxadiazole and cyanobutoxy functionalised pillar[5]arene for detecting Cu2+. Org. Biomol. Chem. 2021, 19, 1287–1291. [Google Scholar] [CrossRef] [PubMed]
  68. Levin, J.I.; Hopper, D.W.; Torres, N.; Dutia, M.D.; Berger, D.M.; Wang, X.; Di Grandi, M.J.; Zhang, C.; Dunnick, A.L. Preparation of bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo [1,5-a] Pyrimidines as Raf Kinase Inhibitors. WO 2009108838 A1, 3 September 2009. [Google Scholar]
  69. Wu, W.-L.; Burnett, D.A.; Stamford, A.W.; Cumming, J.N.; Bennett, C.E.; Gilbert, E.J.; Peng, X.; Scott, J.D.; Yu, Y. Preparation of 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors. WO 2012139425 A1, 18 October 2012. [Google Scholar]
  70. Yu, H.N.; Shin, Y.S.; Park, D.; Yoon, K.J.; Lim, S.K.; Kim, D.; Ki, D.H.; Kim, E.J.; Nam, J.; Han, W.; et al. Preparation of Heterocyclic Carboxamides as SOS1 Inhibitor. WO 2023022497 A1, 23 February 2023. [Google Scholar]
  71. Cordi, A.; Desos, P.; Lestage, P.; Danober, L. Preparation of Phenoxy Dihydrobenzoxathiazepine Derivatives and their Use as Positive Allosteric Modulators of A MPA Receptors. CA 2752131 A1, 16 March 2012. [Google Scholar]
  72. Angell, R.M.; Bamborough, P.; Cockerill, G.S.; Walker, A.L. Preparation of 2′-Methyl-5′-(1,3,4-Oxadiazol-2-yl)-1, 1′-Biphenyl-4-Carboxamides as p38 Kinase Inhibitors. WO 2003032986 A1, 24 April 2003. [Google Scholar]
  73. Wang, K.; Zhang, X.; Cheng, Y.; Qi, Z.; Ye, K.; Zhang, K.; Jiang, S.; Liu, Y.; Xiao, Y.; Wang, T. Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. J. Med. Chem. 2023, 66, 16807–16827. [Google Scholar] [CrossRef] [PubMed]
  74. Zhao, P.; Wang, X.; Zhuang, L.; Wu, H.; Huang, S.; Dong, P.; Li, X.; Hu, Q.; Zhou, Y.; Liu, S.; et al. Preparation of Spiro Compound Derivatives as Raf Inhibitor and Used for Treatment of Cancer. CN 113264945 A, 17 August 2021. [Google Scholar]
  75. Piettre, S.R.; André, C.; Chanal, M.-C.; Ducep, J.-B.; Lesur, B.; Piriou, F.; Raboisson, P.; Rondeau, J.-M.; Schelcher, C.; Zimmermann, P.; et al. Monoaryl- and Bisaryldihydroxytropolones as Potent Inhibitors of Inositol Monophosphatase. J. Med. Chem. 1997, 40, 4208–4221. [Google Scholar] [CrossRef] [PubMed]
  76. Zhang, X.; Wang, J.; Zheng, C.; Li, S. Cumarin Derivative, its Preparation Process and Application in white Light Organic Electroluminescent Device. CN 102101852 A, 22 June 2011. [Google Scholar]
  77. Eastwood, P.R.; Gonzalez Rodriguez, J.; Vidal Juan, B.; Aguilar Izquierdo, N. Preparation of New Substituted Spiro[Cycloalkyl-1, 3′-indol]-2′(1′H)-one Derivatives and their Use as p38 Mitogen–Activated Kinase Inhibitors. WO 2009124692 A1, 15 October 2009. [Google Scholar]
  78. Eastwood, P.; González, J.; Gómez, E.; Caturla, F.; Aguilar, N.; Mir, M.; Aiguadé, J.; Matassa, V.; Balagué, C.; Orellana, A.; et al. Indolin-2-one p38α inhibitors III: Bioisosteric amide replacement. Bioorg. Med. Chem. Lett. 2011, 21, 6253–6257. [Google Scholar] [CrossRef] [PubMed]
  79. Aiguade Bosch, J.; Carranco Moruno, I. Preparation and Compositions of 7-Phenyl-[1,2,4]Triazolo [4,3-a] Pyridin-3(2H)-One Derivatives as p38 MAP Kinase Inhibitors. WO 2011057757 A1, 19 May 2011. [Google Scholar]
  80. De, S.; Kumar, S.K.A.; Shah, S.K.; Kazi, S.; Sarkar, N.; Banerjee, S.; Dey, S. Pyridine: The scaffolds with significant clinical diversity. RSC Adv. 2022, 12, 15385–15406. [Google Scholar] [CrossRef] [PubMed]
  81. Sahu, D.; Sreekanth, P.S.R.; Behera, P.K.; Pradhan, M.K.; Patnaik, A.; Salunkhe, S.; Cep, R. Advances in synthesis, medicinal properties and biomedical applications of pyridine derivatives: A comprehensive review. Eur. J. Med. Chem. Rep. 2024, 12, 100210. [Google Scholar] [CrossRef]
  82. Guan, A.-Y.; Liu, C.-L.; Sun, X.-F.; Xie, Y.; Wang, M.-A. Discovery of pyridine-based agrochemicals by using Intermediate Derivatization Methods. Bioorg. Med. Chem. 2016, 24, 342–353. [Google Scholar] [CrossRef] [PubMed]
  83. Zakharychev, V.V.; Martsynkevich, A.M. Development of novel pyridine-based agrochemicals: A review. Adv. Agrochem. 2025, 4, 30–48. [Google Scholar] [CrossRef]
  84. Cook, X.A.F.; de Gombert, A.; McKnight, J.; Pantaine, L.R.R.; Willis, M.C. The 2-Pyridyl Problem: Challenging Nucleophiles in Cross-Coupling Arylations. Angew. Chem. Int. Ed. 2021, 60, 11068–11091. [Google Scholar] [CrossRef] [PubMed]
  85. Liu, Y.; Milo, L.J., Jr.; Lai, J.H. Recent progress in the synthesis of pyridinylboronic acids and esters. ARKIVOC 2013, 2013, 135–153. [Google Scholar] [CrossRef]
  86. Lee, S.G.; Bae, S.H. Preparation of Urea Compound for Organic Electric Device, Organic Electric Device Using Same, and Electronic Device Thereof. KR 2289502 B1, 13 August 2021. [Google Scholar]
  87. Lee, S.G.; Seo, M.H. Preparation of Organic Compound for Organic Electric Device. KR 2021095268 A, 2 August 2021. [Google Scholar]
  88. Johnson, J.A.; Lloyd, J.; Finlay, H.; Jiang, J.; Neels, J.; Dhondi, N.K.; Gunaga, P.; Banerjee, A.; Adisechan, A. Preparation of 5-Phenylquinazoline Derivatives as Potassium Ion Channel Inhibitors. WO 2011028741 A1, 10 March 2011. [Google Scholar]
  89. Leblanc, C.; Pulz, R.A.; Stiefl, N.J. Preparation of pyrrolopyrimidines and Pyrrolopyridines for Treating ALK-5 and ALK-4 Receptor-Mediated Diseases. WO 2009087225 A2, 16 July 2009. [Google Scholar]
  90. Bist, S.; Dangel, B.; Sherer, B. Preparation of Heterocyclic Urea Derivatives as Antibacterials. WO 2009106885 A1, 3 September 2009. [Google Scholar]
  91. Gordeev, M.F.; Yuan, Z.; Liu, J.; Wang, Q. Indoline Derivatives as Monoamine Oxidase A Inhibitors and their Preparation, Pharmaceutical Compositions and Use in the Treatment of Bacterial Infections. US 20100069441 A1, 18 March 2010. [Google Scholar]
  92. Kumari, A.; Singh, R.K. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. Bioorg. Chem. 2019, 89, 103021. [Google Scholar] [CrossRef] [PubMed]
  93. Duan, S.F.; Song, L.; Guo, H.Y.; Deng, H.; Huang, X.; Shen, Q.K.; Quan, Z.S.; Yin, X.M. Research status of indole-modified natural products. RSC Med. Chem. 2023, 14, 2535–2563. [Google Scholar] [CrossRef] [PubMed]
  94. Erden, K.; Dengiz, C. 3-Alkynylindoles as Building Blocks for the Synthesis of Electronically Tunable Indole-Based Push–Pull Chromophores. J. Org. Chem. 2022, 87, 4385–4399. [Google Scholar] [CrossRef] [PubMed]
  95. Coburn, C.A.; Ludmerer, S.W.; Liu, K.; Wu, H.; Soll, R.; Zhong, B.; Zhu, J. Preparation of Amino Acid and Dipeptide Derivatives as Inhibitors of Hepatitis C Virus Replication. US 20190127365 A1, 2 May 2019. [Google Scholar]
  96. Coburn, C.A.; McCauley, J.A.; Ludmerer, S.W.; Liu, K.; Vacca, J.P.; Wu, H.; Hu, B.; Soll, R.; Sun, F.; Wang, X.; et al. Preparation of L-Prolinamide Derivatives as Inhibitors of Protein NS5A of Hepatitis C Virus. WO 2010111483 A1, 30 September 2010. [Google Scholar]
  97. Wurz, R.P.; Pettus, L.H.; Jackson, C.; Wu, B.; Wang, H.-L.; Herberich, B.; Cee, V.; Lanman, B.A.; Reed, A.B.; Chavez, F.; et al. The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors. Bioorg. Med. Chem. Lett. 2015, 25, 847–855. [Google Scholar] [CrossRef] [PubMed]
  98. Wang, H.-L.; Cee, V.C.; Herberich, B.J.; Jackson, C.L.M.; Lanman, B.A.; Nixey, T.; Pettus, L.H.; Reed, A.B.; Wu, B.; Wurz, R.; et al. Indoles and Related Compounds as PIM Kinase Inhibitors and Their Preparation and Use for the Treatment of P IM Kinase-Related Diseases. WO 2012129338 A1, 27 September 2012. [Google Scholar]
  99. Bakary-Barry, T.; Gallop, M.A.; Barsanti, P.A. Preparation of Indole Compounds as Androgen Receptor Modulators. WO 2022020342 A1, 27 January 2022. [Google Scholar]
  100. Archna, S.P.; Chawla, P.A. Thiophene-based derivatives as anticancer agents: An overview on decade’s work. Bioorg. Chem. 2020, 101, 104026. [Google Scholar] [CrossRef] [PubMed]
  101. Nivrutti, G.P. Furan: A Promising Scaffold for Biological Activity. Int. J. Adv. Biol. Biomed. Res. 2024, 12, 167–181. [Google Scholar] [CrossRef]
  102. Rogacz, D.; Lewkowski, J.; Malinowski, Z.; Matusiak, A.; Morawska, M.; Rychter, P. Effect of New Thiophene-Derived Aminophosphonic Derivatives on Growth of Terrestrial Plants. Part 2. Their Ecotoxicological Impact and Phytotoxicity Test Toward Herbicidal Application in Agriculture. Molecules 2018, 23, 3173. [Google Scholar] [CrossRef] [PubMed]
  103. Barbarella, G.; Zangoli, M.; Di Maria, F. Chapter Three—Synthesis and Applications of Thiophene Derivatives as Organic Materials. Adv. Heterocycl. Chem. 2017, 123, 105–167. [Google Scholar] [CrossRef]
  104. Li, B.; Huang, H. Furan semiconductors and their application in organic field-effect transistors. Mater. Today Nano 2023, 21, 100284. [Google Scholar] [CrossRef]
  105. Zheng, B.; Huo, L. Recent Advances of Furan and Its Derivatives Based Semiconductor Materials for Organic Photovoltaics. Small Methods 2021, 5, 2100493. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Organoboron compounds nomenclature.
Figure 1. Organoboron compounds nomenclature.
Applsci 15 08054 g001
Figure 2. Oxadiazole isomers: 1,2,3-oxadiazole (7), sydnone (8), 1,2,4-oxadiazole (9), 1,2,5-oxadiazole (10), and 1,3,4-oxadiazole (11).
Figure 2. Oxadiazole isomers: 1,2,3-oxadiazole (7), sydnone (8), 1,2,4-oxadiazole (9), 1,2,5-oxadiazole (10), and 1,3,4-oxadiazole (11).
Applsci 15 08054 g002
Figure 3. Number of publications containing the keywords “1,2,5-oxadiazole” (red), “1,2,4-oxadiazole” (blue), and “1,3,4-oxadiazole” (green) since 1980 in the SciFinder database (accessed on 3 March 2025).
Figure 3. Number of publications containing the keywords “1,2,5-oxadiazole” (red), “1,2,4-oxadiazole” (blue), and “1,3,4-oxadiazole” (green) since 1980 in the SciFinder database (accessed on 3 March 2025).
Applsci 15 08054 g003
Figure 4. Examples of 1,3,4-oxadiazole derivatives used in agriculture, medicine, and materials science.
Figure 4. Examples of 1,3,4-oxadiazole derivatives used in agriculture, medicine, and materials science.
Applsci 15 08054 g004
Figure 5. Application of 1,3,4-oxadiazole boronic acid derivatives in materials science and medicinal chemistry fields.
Figure 5. Application of 1,3,4-oxadiazole boronic acid derivatives in materials science and medicinal chemistry fields.
Applsci 15 08054 g005
Scheme 1. Lithiation borylation methodology in phenyl halides (19) leading to phenylboronic acid (22) via intermediates: phenyllithium/phenylmagnesium halide (20) and trialkoxyphenylborate (21).
Scheme 1. Lithiation borylation methodology in phenyl halides (19) leading to phenylboronic acid (22) via intermediates: phenyllithium/phenylmagnesium halide (20) and trialkoxyphenylborate (21).
Applsci 15 08054 sch001
Scheme 2. Miyaura borylation approach in the preparation of phenylboronic acid pinacol ester (23).
Scheme 2. Miyaura borylation approach in the preparation of phenylboronic acid pinacol ester (23).
Applsci 15 08054 sch002
Scheme 3. Three synthetic approaches to 1,3,4-oxadiazole boronic acid derivatives proceeding via cyclization of the intermediate diacylhydrazines (26), thiosemicarbazides (29), and acylhydrazones (31).
Scheme 3. Three synthetic approaches to 1,3,4-oxadiazole boronic acid derivatives proceeding via cyclization of the intermediate diacylhydrazines (26), thiosemicarbazides (29), and acylhydrazones (31).
Applsci 15 08054 sch003
Scheme 4. Lithiation borylation of 2-bromo-1,3,4-oxadiazole derivatives (33) leading to 1,3,4-oxadiazole boronic acid (34); (a) n-BuLi, THF, trimethyl borate, −78 °C; (b) n-BuLi, toluene, triisopropyl borate, −45 °C; then aq. HCl.
Scheme 4. Lithiation borylation of 2-bromo-1,3,4-oxadiazole derivatives (33) leading to 1,3,4-oxadiazole boronic acid (34); (a) n-BuLi, THF, trimethyl borate, −78 °C; (b) n-BuLi, toluene, triisopropyl borate, −45 °C; then aq. HCl.
Applsci 15 08054 sch004
Scheme 5. (A) One-pot, two-step approach to borylated 1,3,4-oxadiazoles (37a,b) from carboxy-MIDA boronic ester (35); (a) HATU, DIPEA, ACN, 0 °C, 20 min; (b) p-TsCl, rt, 2 h; (B) carboxy-MIDA boronic ester (35) synthesis from ethynyl-MIDA boronic ester (38); (c) RuCl3·3H2O, H5IO6, ACN, rt, 45 min.
Scheme 5. (A) One-pot, two-step approach to borylated 1,3,4-oxadiazoles (37a,b) from carboxy-MIDA boronic ester (35); (a) HATU, DIPEA, ACN, 0 °C, 20 min; (b) p-TsCl, rt, 2 h; (B) carboxy-MIDA boronic ester (35) synthesis from ethynyl-MIDA boronic ester (38); (c) RuCl3·3H2O, H5IO6, ACN, rt, 45 min.
Applsci 15 08054 sch005
Figure 6. Distribution of publication types concerning ortho, meta, and para isomers of boronic acid and its derivatives linked to 1,3,4-oxadiazole via a phenylene linker, as determined via the SciFinder database (accessed 3 March 2025).
Figure 6. Distribution of publication types concerning ortho, meta, and para isomers of boronic acid and its derivatives linked to 1,3,4-oxadiazole via a phenylene linker, as determined via the SciFinder database (accessed 3 March 2025).
Applsci 15 08054 g006
Scheme 6. Synthesis of para-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol esters (40) from aryl halides (39ac) or pseudo aryl halides (39d).
Scheme 6. Synthesis of para-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol esters (40) from aryl halides (39ac) or pseudo aryl halides (39d).
Applsci 15 08054 sch006
Scheme 7. Synthesis of 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid (42) from 2-(4-bromophenyl)-1,3,4-oxadiazole (41) and its conversion into the corresponding trifluoroborate (43); (a) B2(OH)4, XPhos Pd G2, AcOK, EtOH, 80 °C, 2 h; (b) aq. KHF2.
Scheme 7. Synthesis of 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid (42) from 2-(4-bromophenyl)-1,3,4-oxadiazole (41) and its conversion into the corresponding trifluoroborate (43); (a) B2(OH)4, XPhos Pd G2, AcOK, EtOH, 80 °C, 2 h; (b) aq. KHF2.
Applsci 15 08054 sch007
Scheme 8. Transformation of 1,3,4-oxadiazole-containing aryl bromides (39b) into the corresponding 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids (44) or its pinacol esters (40).
Scheme 8. Transformation of 1,3,4-oxadiazole-containing aryl bromides (39b) into the corresponding 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids (44) or its pinacol esters (40).
Applsci 15 08054 sch008
Scheme 9. The synthesis of 1,3,4-oxadiazole boronic acid derivatives. Reagents and conditions: (A) (a) 4-carboxylphenylboronic acid pinacol ester (45a) and hydrazide, or 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b) and carboxylic acid, PPh3, CCl3CN, MW, 130 °C, 2 h; (b) 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (40), sodium periodate, ammonium acetate, acetone/water 2:1, 12 h, 23 °C or H2SO4, 10 min, 23 °C; (B) (c) 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b), triethyl orthoformate, reflux; (d) 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid (46), 5% AcOH, 24 h, room temperature; (C) (e) 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b), S-ethylated thioamide (47), n-BuOH, 24 h, N2, reflux; (f) 4-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (48), aq. KHF2, MeOH, 1 h; (g) potassium 4-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyltrifluoroborate (49), LiOH, H2O, 24 h, rt then NH4Cl, HCl.
Scheme 9. The synthesis of 1,3,4-oxadiazole boronic acid derivatives. Reagents and conditions: (A) (a) 4-carboxylphenylboronic acid pinacol ester (45a) and hydrazide, or 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b) and carboxylic acid, PPh3, CCl3CN, MW, 130 °C, 2 h; (b) 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (40), sodium periodate, ammonium acetate, acetone/water 2:1, 12 h, 23 °C or H2SO4, 10 min, 23 °C; (B) (c) 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b), triethyl orthoformate, reflux; (d) 4-(1,3,4-oxadiazol-2-yl)phenylboronic acid (46), 5% AcOH, 24 h, room temperature; (C) (e) 4-(hydrazinecarbonyl)phenylboronic acid pinacol ester (45b), S-ethylated thioamide (47), n-BuOH, 24 h, N2, reflux; (f) 4-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (48), aq. KHF2, MeOH, 1 h; (g) potassium 4-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyltrifluoroborate (49), LiOH, H2O, 24 h, rt then NH4Cl, HCl.
Applsci 15 08054 sch009
Scheme 10. The synthesis of [4-(5-amino)-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid derivative (52a) and [4-(5-amino)-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid pinacol ester derivative (52b) via N1-benzoylthiosemicarbazide (51) cyclization; (a) EDC, DMSO, 50–60 °C.
Scheme 10. The synthesis of [4-(5-amino)-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid derivative (52a) and [4-(5-amino)-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid pinacol ester derivative (52b) via N1-benzoylthiosemicarbazide (51) cyclization; (a) EDC, DMSO, 50–60 °C.
Applsci 15 08054 sch010
Scheme 11. Synthesis of meta-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (54) from aryl halides (53ac).
Scheme 11. Synthesis of meta-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (54) from aryl halides (53ac).
Applsci 15 08054 sch011
Scheme 12. EDC-mediated synthesis of 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (57) from 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (55) and 4-phenylthiosemicarbazide (56); (a) 3 eq EDC, MeOH, THF, 65 °C, 2 h.
Scheme 12. EDC-mediated synthesis of 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (57) from 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (55) and 4-phenylthiosemicarbazide (56); (a) 3 eq EDC, MeOH, THF, 65 °C, 2 h.
Applsci 15 08054 sch012
Scheme 13. The formation of 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (54) via cyclization of 3-(2-acylhydrazinecarbonyl)phenylboronic acid pinacol ester (58) promoted by tosyl chloride; (a) p-TsCl, DIPEA, DCM, rt, 18 h or ACN, 40 °C, 12 h.
Scheme 13. The formation of 3-[5-(phenylamino)-1,3,4-oxadiazol-2-yl]phenylboronic acid pinacol ester (54) via cyclization of 3-(2-acylhydrazinecarbonyl)phenylboronic acid pinacol ester (58) promoted by tosyl chloride; (a) p-TsCl, DIPEA, DCM, rt, 18 h or ACN, 40 °C, 12 h.
Applsci 15 08054 sch013
Scheme 14. Halogen–metal–boron exchange in meta-substituted phenylboronic acid of 1,3,4-oxadiazole (59) synthesis; (a) 2-(3-bromophenyl)-1,3,4-oxadiazole (53a), n-BuLi, B(O-i-Pr)3 or B(OMe)3 trimethyl borate, THF −78 °C; then aq. HCl; (b) 2-(3-iodophenyl)-1,3,4-oxadiazole (53b), i-PrMgCl, B(O-i-Pr)3, THF, −10 °C, then aq. HCl.
Scheme 14. Halogen–metal–boron exchange in meta-substituted phenylboronic acid of 1,3,4-oxadiazole (59) synthesis; (a) 2-(3-bromophenyl)-1,3,4-oxadiazole (53a), n-BuLi, B(O-i-Pr)3 or B(OMe)3 trimethyl borate, THF −78 °C; then aq. HCl; (b) 2-(3-iodophenyl)-1,3,4-oxadiazole (53b), i-PrMgCl, B(O-i-Pr)3, THF, −10 °C, then aq. HCl.
Applsci 15 08054 sch014
Scheme 15. The lithiation borylation (method A) and Miyaura borylation (method B) strategies in the synthesis of ortho-substituted phenylboronic acid of 1,3,4-oxadiazole derivatives (61,62). Method A: 2-(2-bromophenyl)-1,3,4-oxadiazole derivative (60a), toluene/THF, −78 °C, B(O-i-Pr)3, n-BuLi, then 2M HCl; Method B: 2-(2-bromophenyl)-1,3,4-oxadiazole derivative (60a), B2(pin)2, Pd(dppf)2Cl2, AcOK, DMSO, 80 °C, 2–8 h, then 0.2M H2SO4; or 2-(2-chlorophenyl)-1,3,4-oxadiazole derivative (60b), B(pin)2, Pd(AcO)2, P(Cy)3, AcOK, 1,4-dioxane, 100 °C, 2 h.
Scheme 15. The lithiation borylation (method A) and Miyaura borylation (method B) strategies in the synthesis of ortho-substituted phenylboronic acid of 1,3,4-oxadiazole derivatives (61,62). Method A: 2-(2-bromophenyl)-1,3,4-oxadiazole derivative (60a), toluene/THF, −78 °C, B(O-i-Pr)3, n-BuLi, then 2M HCl; Method B: 2-(2-bromophenyl)-1,3,4-oxadiazole derivative (60a), B2(pin)2, Pd(dppf)2Cl2, AcOK, DMSO, 80 °C, 2–8 h, then 0.2M H2SO4; or 2-(2-chlorophenyl)-1,3,4-oxadiazole derivative (60b), B(pin)2, Pd(AcO)2, P(Cy)3, AcOK, 1,4-dioxane, 100 °C, 2 h.
Applsci 15 08054 sch015
Scheme 16. Cyclization approach in ortho-substituted phenylboronic acid (61) and boronic pinacol ester (62) of 1,3,4-oxadiazole derivatives synthesis from benzohydrazide 2-boronic acid pinacol ester (63) or 4-carboxyphenylboronic acid pinacol ester (64); (a) CCl3CN, PPh3, ACN, 130 °C, 2 h; (b) ammonium acetate, sodium periodate, acetone, 23 °C, H2O, 12 h.
Scheme 16. Cyclization approach in ortho-substituted phenylboronic acid (61) and boronic pinacol ester (62) of 1,3,4-oxadiazole derivatives synthesis from benzohydrazide 2-boronic acid pinacol ester (63) or 4-carboxyphenylboronic acid pinacol ester (64); (a) CCl3CN, PPh3, ACN, 130 °C, 2 h; (b) ammonium acetate, sodium periodate, acetone, 23 °C, H2O, 12 h.
Applsci 15 08054 sch016
Figure 7. Frequency of papers containing heteroaromatic bridging units linking 1,3,4-oxadiazole to boronic acids or esters as determined via the SciFinder database (accessed on 3 March 2025).
Figure 7. Frequency of papers containing heteroaromatic bridging units linking 1,3,4-oxadiazole to boronic acids or esters as determined via the SciFinder database (accessed on 3 March 2025).
Applsci 15 08054 g007
Figure 8. Boronic acid derivatives and 1,3,4-oxadiazole exit vectors from pyridine linkers: 6-(1,3,4-oxadiazol-2-yl)pyridin-2-ylboronic acid (65), (5-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (66), 4-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (67) and 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (68).
Figure 8. Boronic acid derivatives and 1,3,4-oxadiazole exit vectors from pyridine linkers: 6-(1,3,4-oxadiazol-2-yl)pyridin-2-ylboronic acid (65), (5-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (66), 4-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (67) and 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (68).
Applsci 15 08054 g008
Scheme 17. Miyaura borylation of 1,3-bis(5-(6-bromopyridin-2-yl)-1,3,4-oxadiazol-2-yl)benzene (69) leading to 6,6′-(5,5′-(1,3-phenylene)bis(1,3,4-oxadiazole-5,2-diyl))bis(pyridine-6,2-diyl)diboronic acid dipinacol ester (70); (a) B2(pin)2, Pd(Ph3)4, AcOK, 1,4-dioxane, 110 °C.
Scheme 17. Miyaura borylation of 1,3-bis(5-(6-bromopyridin-2-yl)-1,3,4-oxadiazol-2-yl)benzene (69) leading to 6,6′-(5,5′-(1,3-phenylene)bis(1,3,4-oxadiazole-5,2-diyl))bis(pyridine-6,2-diyl)diboronic acid dipinacol ester (70); (a) B2(pin)2, Pd(Ph3)4, AcOK, 1,4-dioxane, 110 °C.
Applsci 15 08054 sch017
Figure 9. The 1,3,4-oxadiazolole and pinacol boronic ester conjugates connected by pyridine linkers: 5-(1,3,4-oxadiazol-2-yl)-pyridin-3-ylboronic acid pinacol ester (71), 4-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester (72), 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester (73).
Figure 9. The 1,3,4-oxadiazolole and pinacol boronic ester conjugates connected by pyridine linkers: 5-(1,3,4-oxadiazol-2-yl)-pyridin-3-ylboronic acid pinacol ester (71), 4-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester (72), 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid pinacol ester (73).
Applsci 15 08054 g009
Scheme 18. The lithiation borylation approach in the synthesis of 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (75) from 5-bromo-2-(1,3,4-oxadiazol-2-yl)pyridine (75); (a) B(O-i-Pr)3, n-BuLi, toluene/THF, −78 °C; (b) 2M HCl, 23 °C.
Scheme 18. The lithiation borylation approach in the synthesis of 6-(1,3,4-oxadiazol-2-yl)pyridin-3-ylboronic acid (75) from 5-bromo-2-(1,3,4-oxadiazol-2-yl)pyridine (75); (a) B(O-i-Pr)3, n-BuLi, toluene/THF, −78 °C; (b) 2M HCl, 23 °C.
Applsci 15 08054 sch018
Figure 10. 1,3,4-Oxadiazole and boron derivative conjugates connected by indole linkers: 1-Boc-6-(1,3,4-oxadiazol-2-yl)indol-2-ylboronic acid (76), 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (77) and its pinacol ester (78), 1-SEM-7-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (79).
Figure 10. 1,3,4-Oxadiazole and boron derivative conjugates connected by indole linkers: 1-Boc-6-(1,3,4-oxadiazol-2-yl)indol-2-ylboronic acid (76), 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (77) and its pinacol ester (78), 1-SEM-7-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (79).
Applsci 15 08054 g010
Scheme 19. Borylation of 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indole (80) leading to 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indol-2-ylboronic acid (76) via the C–H activation of indole ring; (a) B(O-i-Pr)3, LDA, THF, 0 °C; (b) aq. HCl, rt.
Scheme 19. Borylation of 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indole (80) leading to 1-Boc-6-[5-(1-(benzyloxycarbonyl)pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]indol-2-ylboronic acid (76) via the C–H activation of indole ring; (a) B(O-i-Pr)3, LDA, THF, 0 °C; (b) aq. HCl, rt.
Applsci 15 08054 sch019
Scheme 20. Miyaura borylation in halogen substituted indoles connected to 1,3,4-oxadiazole core leading to: 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (77), 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid pinacol ester (78) and 1-SEM-7-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (79); (A) (a) 3-iodo-1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indole (81), B2(pin)2, Pd(dppf)Cl2, AcOK, DMF, 90 °C, 1 h; (B) (b) 1-SEM-3-bromo-7-(1,3,4-oxadiazol-2-yl)indole (82), B2(pin)2, Pd(dppf)Cl2, AcOK, 1,4-dioxane, 80 °C, overnight.
Scheme 20. Miyaura borylation in halogen substituted indoles connected to 1,3,4-oxadiazole core leading to: 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (77), 1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid pinacol ester (78) and 1-SEM-7-(1,3,4-oxadiazol-2-yl)indol-3-ylboronic acid (79); (A) (a) 3-iodo-1-(p-toluenesulfonyl)-5-(1,3,4-oxadiazol-2-yl)indole (81), B2(pin)2, Pd(dppf)Cl2, AcOK, DMF, 90 °C, 1 h; (B) (b) 1-SEM-3-bromo-7-(1,3,4-oxadiazol-2-yl)indole (82), B2(pin)2, Pd(dppf)Cl2, AcOK, 1,4-dioxane, 80 °C, overnight.
Applsci 15 08054 sch020
Figure 11. Boronic acid derivatives of 1,3,4-oxadiazole containing thiophene, furan, and ethenylbenzene linkers: 5,5′-(1,3,4-oxadiazole-2,5-diyl)bis(thiophene-5,2-diyl)diboronic acid dipinacol ester (83), 5-(1,3,4-oxadiazol-2-yl)thiophen-3-ylboronic acid (84), 5-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (85), 3-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (86), 4-(1,3,4-oxadiazol-2-yl)furan-2-ylboronic acid (87), 2-(2-(5-methyl-1,3,4-oxadiazol-2-yl)vinyl)phenylboronic acid (88).
Figure 11. Boronic acid derivatives of 1,3,4-oxadiazole containing thiophene, furan, and ethenylbenzene linkers: 5,5′-(1,3,4-oxadiazole-2,5-diyl)bis(thiophene-5,2-diyl)diboronic acid dipinacol ester (83), 5-(1,3,4-oxadiazol-2-yl)thiophen-3-ylboronic acid (84), 5-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (85), 3-(1,3,4-oxadiazol-2-yl)thiophen-2-ylboronic acid (86), 4-(1,3,4-oxadiazol-2-yl)furan-2-ylboronic acid (87), 2-(2-(5-methyl-1,3,4-oxadiazol-2-yl)vinyl)phenylboronic acid (88).
Applsci 15 08054 g011
Figure 12. Dibenzofuran, dibenzothiophene, naphthalene, and biphenyl bridges between 1,3,4-oxadiazole and pinacol boronic ester in 7-(1,3,4-oxadiazol-2-yl)dibenzo[b,d]furan-2-ylboronic acid pinacol ester (89), 1-(5-phenyl-1,3,4-oxadiazol-2-yl)dibenzo[b,d]thiophen-4-ylboronic acid pinacol ester (90), substituted 4-(1,3,4-oxadiazol-2-yl)naphthalen-1-ylboronic acid pinacol ester (91), 6-(1,3,4-oxadiazol-2-yl)naphthalen-1-ylboronic acid pinacol ester (92), 3′-(1,3,4-oxadiazol-2-yl)biphenyl-3-ylboronic acid pinacol ester (93), substituted 4′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-4-ylboronic acid pinacol esters (94), 3′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-2-ylboronic acid pinacol ester (95).
Figure 12. Dibenzofuran, dibenzothiophene, naphthalene, and biphenyl bridges between 1,3,4-oxadiazole and pinacol boronic ester in 7-(1,3,4-oxadiazol-2-yl)dibenzo[b,d]furan-2-ylboronic acid pinacol ester (89), 1-(5-phenyl-1,3,4-oxadiazol-2-yl)dibenzo[b,d]thiophen-4-ylboronic acid pinacol ester (90), substituted 4-(1,3,4-oxadiazol-2-yl)naphthalen-1-ylboronic acid pinacol ester (91), 6-(1,3,4-oxadiazol-2-yl)naphthalen-1-ylboronic acid pinacol ester (92), 3′-(1,3,4-oxadiazol-2-yl)biphenyl-3-ylboronic acid pinacol ester (93), substituted 4′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-4-ylboronic acid pinacol esters (94), 3′-(5-phenyl-1,3,4-oxadiazol-2-yl)biphenyl-2-ylboronic acid pinacol ester (95).
Applsci 15 08054 g012
Table 1. Publications on boronic acid and its derivatives linked to 1,3,4-oxadiazole via ortho-, meta-, and para-substituted phenyl groups as determined via the SciFinder database (accessed on 3 March 2025).
Table 1. Publications on boronic acid and its derivatives linked to 1,3,4-oxadiazole via ortho-, meta-, and para-substituted phenyl groups as determined via the SciFinder database (accessed on 3 March 2025).
Publication TypeApplsci 15 08054 i001
para
Applsci 15 08054 i002
meta
Applsci 15 08054 i003
ortho
Journals1870
Patents28292
Table 2. Miyaura borylation conditions for para-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol esters (40).
Table 2. Miyaura borylation conditions for para-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol esters (40).
EntryCatalystLigand 1SolventTemp./TimeYieldRefs.
X = Cl (39a)
1Pd(AcO)2ATHF110 °C/20 h79%[17]
2Pd(AcO)2B1,4-dioxane100 °C/20 h84–88%[21]
3Pd(dppf)Cl2-1,4-dioxane80 °C/onna[22]
4Pd2(dba)3C1,4-dioxane85 °C/onna[23]
X = Br (39b)
5Pd(dppf)Cl2-1,4-dioxane100 °C/na or on or 2 h80–92%[24,25,26,27,28]
6Pd(dppf)Cl2-1,4-dioxane90 °C/2 h70–85%[29]
7Pd(dppf)Cl2-1,4-dioxane80 °C/na or 12 h–4 d21–78%[28,29,30,31,32,33]
8Pd(dppf)Cl2-DMF90 °C/na78%[34]
9Pd(dppf)Cl2-DMF80 °C/15–16 h51–83%[35,36]
10Pd(dppf)Cl2-DMSO80 °C/4–24 h45–61%[37,38]
11Pd(dppf)Cl2-DMSO80 °C/on83%[39]
12Pd(dppf)Cl2-DME80 °C/on81%[40]
13Pd(dppf)Cl2·DCM-1,4-dioxane80 °C/2 h77–88%[41]
14Pd(dppf)Cl2·DCM-1,4-dioxane90 °C/12 hna[42]
15Pd(dppf)Cl2·DCM-DMF80 °C/12 h53%[43]
16CuI, Pd(dppf)Cl2-DMF90 °C/12 h82%[44]
X = I (39c)
17Pd(PPh3)4-1,4-dioxane100 °C/12 h22% 2[45]
X = OTf (39d)
18Pd(dppf)Cl2-DMF95 °C/on86%[46]
1 A: 1,3-Bis(2,6-diisopropylphenyl) imidazolium chloride, B: P(Cy)3, C: 2′-(Dicyclohexylphosphino)-N,N-dimethyl [1,1′-biphenyl]-2-amine. 2 Both pinacol boronic ester and boronic acid were products of the reaction. Yield of isolated boronic acid via prep. HPLC purification. on—overnight, na—data not available.
Table 3. Lithiation borylation conditions for the synthesis of 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids (44) or its pinacol esters (40).
Table 3. Lithiation borylation conditions for the synthesis of 4-(1,3,4-oxadiazol-2-yl)phenylboronic acids (44) or its pinacol esters (40).
EntryLithium SourceBoron Source 1SolventTemp.YieldProductRef.
1n-BuLiAEt2Onana44[48,49]
2n-BuLiATHF−40 °C to −78 °C81%44[18]
3n-BuLiATHF−50 °C42%44[50]
4n-BuLiATHF−78 °C74%44[51]
5n-BuLiAToluene/THF−78 °C62%44[39]
6n-BuLiBToluene/THF−78 °Cna44[15]
7n-BuLiCTHFNa61% 240[52]
8a1. MeLi
2. n-BuLi
BTHF−65 °C82%44[53]
8b1. Li, 4-chlorotoluene
2. n-HexLi
BTHF−35 °C to −65 °C89%44
8c1. Li, 2-chlorotoluene, biphenyl
2. n-HexLi
ATHF−30 °C to −65 °C60%44
8d1. Li, 2-chlorotoluene
2. n-HexLi
ATHF−30 °C to −65 °C76%44
8e1. Li, chlorobenzene, biphenyl
2. n-HexLi
ATHF−30 °C to −65 °C84%44
1 A: trimethyl borate, B: triisopropyl borate, C: isopropylboronic acid pinacol ester. 2 Total yield after six-step synthesis.
Table 4. Miyaura borylation conditions for meta-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (54).
Table 4. Miyaura borylation conditions for meta-substituted (1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester (54).
EntryCatalystLigand 1SolventTemp./TimeYieldRefs.
X = Br (53a)
1Pd(dppf)Cl2-1,4-dioxane120 °C/20 min or on44–90%[55]
2Pd(dppf)Cl2-1,4-dioxane100 °C/6 h53–80%[56]
3Pd(dppf)Cl2-1,4-dioxane90 °C/on99%[57]
4Pd(dppf)Cl2-1,4-dioxane85 °C/on88–90%[58]
5Pd(dppf)Cl2·DCM-DMSO130 °C/45 min62%[59]
6Pd(dppf)Cl2·DCM-DMSO80 °C/16 hna[60,61]
7Pd(dppf)Cl2·DCM-DMSO80 °C/18 hna[62]
8Pd(dppf)Cl2·DCM-DMF90 °C/15 h76%[63]
9Pd(dppf)Cl2·DCM-DMF80 °C/12 h71%[40]
10Pd(dppf)Cl2-THF85 °C/12 h80%[64]
11Pd(dppf)Cl2-dimethoxyethane101 °C/14 h or 120 °C/45 minna[65,66]
12Pd(PPh3)2Cl2-1,4-dioxanen/a35% 2[67]
13Pd(PPh3)2Cl2-DMSO80 °C/4.5 h22%[68]
14Pd(AcO)2ATHF101 °C/2 hn/a[61]
15Pd(AcO)2ATHF75 °C/2 h78%[69]
16Pd(AcO)2ATHF75 °C/3 h84%[70]
X = I (53b)
17Pd(AcO)2-DMF85 °C/3 hna[71]
18Pd(dppf)Cl2-DMF80 °C/4 hna[72]
X = Cl (53c)
19Pd(AcO)2B1,4-dioxane101 °C79–85%[21]
1 A: 1,3-Bis(2,6-diisopropylphenyl)imidazolium chloride, B: P(Cy)3. 2 Yield after three-step synthesis. on—overnight, na—data not available.
Table 5. Miyaura borylation conditions for (1,3,4-oxadiazol-2-yl)pyridines (71–73).
Table 5. Miyaura borylation conditions for (1,3,4-oxadiazol-2-yl)pyridines (71–73).
EntryProductCatalystSolventBaseTemp./TimeYieldRef.
171a, R1 = NH2Pd(dppf)Cl2·DCM1,4-dioxane 1AcOK120 °C/45 minna[88]
271b, R1 = HPd(dppf)Cl2ACN 1AcOK160 °C/15 minna[89]
371b, R1 = HPd(dppf)Cl2DMSOAcOK80 °C/24h15%[69]
472Pd(PPh3)2Cl21,4-dioxaneAcOK70 °C/12.5h76%[90]
573Pd(dppf)Cl2·DCMDMSOAcOK, Et3N80 °C/2h35%[91]
1 Microwave irradiation. na—not available.
Table 6. A summary of three approaches for the synthesis of 1,3,4-oxadiazole-containing organoboron derivatives.
Table 6. A summary of three approaches for the synthesis of 1,3,4-oxadiazole-containing organoboron derivatives.
Method AMethod BMethod C
Advantages
  • Wide range of aromatic and heteroaromatic compounds
  • The main byproducts are inorganic salts and alcohols
  • Relatively low costs of organometallic base for larger scale
  • Simple work-up/purification via precipitation or pH-dependent extraction
  • Provide direct access to boronic acid
  • High functional group tolerance
  • Mild reaction conditions without highly reactive organometallic bases
  • Relatively mild temperatures (up to 100 °C)
  • Catalytic amounts of palladium, resulting in less metal waste
  • Direct production of the more stable boronic pinacol esters, which are easier to purify and handle than free boronic acids
  • Compatible with various functional groups
  • Multiple synthetic routes available for oxadiazole core synthesis
  • Mild reaction conditions
Limitations
  • Very low functional group tolerance
  • Harsh conditions (cryogenic temperatures, strong bases, and potent nucleophiles)
  • Sensitive to moisture and oxygen
  • Utilizes highly reactive organometallic bases that react violently with water
  • Possibility of competing side reactions (e.g., Wurtz-type coupling)
  • Relatively high costs of palladium catalysts and bis(pinacolato)diboron for large-scale synthesis
  • Removal of palladium traces can be challenging
  • Requires an inert atmosphere
  • Requires precursors with a boronic ester moiety for complex targets
Average yield22–88%40–99%43–77%
ApplicabilityBromides, IodidesChlorides, Bromides, Iodides, TriflatesCarboxylic acids, Hydrazides, Thiosemicarbazides
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wołek, B.; Kudelko, A. Synthetic Approaches to 1,3,4-Oxadiazole-Containing Boronic Derivatives. Appl. Sci. 2025, 15, 8054. https://doi.org/10.3390/app15148054

AMA Style

Wołek B, Kudelko A. Synthetic Approaches to 1,3,4-Oxadiazole-Containing Boronic Derivatives. Applied Sciences. 2025; 15(14):8054. https://doi.org/10.3390/app15148054

Chicago/Turabian Style

Wołek, Barbara, and Agnieszka Kudelko. 2025. "Synthetic Approaches to 1,3,4-Oxadiazole-Containing Boronic Derivatives" Applied Sciences 15, no. 14: 8054. https://doi.org/10.3390/app15148054

APA Style

Wołek, B., & Kudelko, A. (2025). Synthetic Approaches to 1,3,4-Oxadiazole-Containing Boronic Derivatives. Applied Sciences, 15(14), 8054. https://doi.org/10.3390/app15148054

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop